Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Clarke, Ba"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 32
Tytuł:
'It was not chest pain really, I can't explain it!' An exploratory study on the nature of symptoms experienced by women during their myocardial infarction.
Autorzy:
Albarran JW
Clarke BA
Crawford J
Pokaż więcej
Źródło:
Journal of Clinical Nursing (Wiley-Blackwell); Jul2007, Vol. 16 Issue 7, p1292-1301, 10p
Czasopismo naukowe
Szczegóły
Tytuł:
Metastatic low-grade endometrial stromal sarcoma of uterus presenting as a primary pancreatic tumor: case presentation and literature review.
Autorzy:
McCarthy AJ; Department of Anatomical Pathology, Laboratory Medicine Program, University Health Network, Toronto General Hospital, 200 Elizabeth Street, 11th Floor, Eaton Wing, Toronto, Ontario, M5G 2C4, Canada. .; Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. .
Clarke BA; Department of Anatomical Pathology, Laboratory Medicine Program, University Health Network, Toronto General Hospital, 200 Elizabeth Street, 11th Floor, Eaton Wing, Toronto, Ontario, M5G 2C4, Canada.; Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
McGilvray I; Surgery and Critical Care Program, Division of General Surgery, University Health Network, Toronto, Ontario, Canada.; Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
Dickson BC; Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Department of Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.
Khalili K; Joint Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada.; Department of Radiology, University of Toronto, Toronto, Ontario, Canada.
Chetty R; Department of Anatomical Pathology, Laboratory Medicine Program, University Health Network, Toronto General Hospital, 200 Elizabeth Street, 11th Floor, Eaton Wing, Toronto, Ontario, M5G 2C4, Canada.; Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Pokaż więcej
Źródło:
Diagnostic pathology [Diagn Pathol] 2019 Apr 22; Vol. 14 (1), pp. 30. Date of Electronic Publication: 2019 Apr 22.
Typ publikacji:
Case Reports; Journal Article; Review
MeSH Terms:
Biomarkers, Tumor/*analysis
Endometrial Neoplasms/*diagnosis
Leiomyoma/*diagnosis
Pancreatic Neoplasms/*diagnosis
Sarcoma, Endometrial Stromal/*diagnosis
Endometrial Neoplasms/secondary ; Endometrial Neoplasms/surgery ; Epithelioid Cells/pathology ; Female ; Humans ; Hysterectomy ; Immunohistochemistry ; Leiomyoma/pathology ; Leiomyoma/surgery ; Middle Aged ; Pancreas/pathology ; Pancreatic Neoplasms/pathology ; Sarcoma, Endometrial Stromal/secondary ; Sarcoma, Endometrial Stromal/surgery ; Uterus/pathology ; Uterus/surgery
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Expanding the morphological spectrum of ovarian microcystic stromal tumour.
Autorzy:
McCluggage WG; Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK.
Chong AS; Cancer Research Program, Research Institute, McGill University Health Centre, Montreal, QC, Canada.
Attygalle AD; Department of Pathology, Royal Marsden Hospital, London, UK.
Clarke BA; Department of Laboratory Medicine and Pathobiology, University of Toronto, University Health Network, Toronto, ON, Canada.
Chapman W; Department of Laboratory Medicine and Pathobiology, University of Toronto, University Health Network, Toronto, ON, Canada.
Rivera B; Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada.; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, Canada.
Foulkes WD; Cancer Research Program, Research Institute, McGill University Health Centre, Montreal, QC, Canada.; Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada.; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, Canada.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2019 Feb; Vol. 74 (3), pp. 443-451. Date of Electronic Publication: 2018 Dec 05.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Ovarian Neoplasms/*pathology
Sex Cord-Gonadal Stromal Tumors/*pathology
Aged ; Biomarkers, Tumor/analysis ; DNA Mutational Analysis ; Female ; Humans ; Middle Aged ; Ovarian Neoplasms/genetics ; Point Mutation ; Sex Cord-Gonadal Stromal Tumors/genetics ; beta Catenin/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Inhibitory Projections in the Mouse Auditory Tectothalamic System.
Autorzy:
Clarke BA; Department of Comparative Biomedical Sciences, LSU School of Veterinary Medicine, Baton Rouge, LA 70803, USA. .
Lee CC; Department of Comparative Biomedical Sciences, LSU School of Veterinary Medicine, Baton Rouge, LA 70803, USA. .
Pokaż więcej
Źródło:
Brain sciences [Brain Sci] 2018 Jun 09; Vol. 8 (6). Date of Electronic Publication: 2018 Jun 09.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical, morphological and immunohistochemical evidence that small-cell carcinoma of the ovary of hypercalcaemic type (SCCOHT) may be a primitive germ-cell neoplasm.
Autorzy:
McCluggage WG; Department of Pathology, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK.
Witkowski L; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
Clarke BA; Department of Laboratory Medicine and Pathobiology, University of Toronto, University Health Network, Toronto, Ontario, Canada.
Foulkes WD; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2017 Jun; Vol. 70 (7), pp. 1147-1154. Date of Electronic Publication: 2017 Mar 20.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Carcinoma, Small Cell/*pathology
Neoplasms, Germ Cell and Embryonal/*pathology
Ovarian Neoplasms/*pathology
Adult ; Biomarkers, Tumor/analysis ; Female ; Humans ; Hypercalcemia ; Immunohistochemistry
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Loss of SMARCA4 (BRG1) protein expression as determined by immunohistochemistry in small-cell carcinoma of the ovary, hypercalcaemic type distinguishes these tumours from their mimics.
Autorzy:
Clarke BA; Department of Laboratory Medicine and Pathobiology, University of Toronto, University Health Network, Toronto, ON, Canada. blaise.clarke@uhn.ca.; Toronto General Hospital, Toronto, ON, Canada. blaise.clarke@uhn.ca.
Witkowski L; Department of Human Genetics, McGill University, Montreal, QC, Canada.; Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, Montreal, QC, Canada.
Ton Nu TN; Department of Pathology, McGill University Health Centre, Montreal, QC, Canada.
Shaw PA; Department of Laboratory Medicine and Pathobiology, University of Toronto, University Health Network, Toronto, ON, Canada.; Toronto General Hospital, Toronto, ON, Canada.
Gilks CB; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada.; Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, BC, Canada.
Huntsman D; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada.; Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, BC, Canada.
Karnezis AN; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada.; Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, BC, Canada.
Sebire N; Department of Histopathology, Great Ormond Street Hospital, London, UK.; Institute of Child Health, University College London, London, UK.
Lamovec J; Department of Pathology, Institute of Oncology, Ljubljana, Slovenia.
Roth LM; Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, USA.
Stewart CJ; School for Women's and Infants' Health, University of Western Australia, Perth, WA, Australia.; KEMH, Perth, WA, Australia.
Hasselblatt M; Institute of Neuropathology, University Hospital Münster, Münster, Germany.
Foulkes WD; Department of Human Genetics, McGill University, Montreal, QC, Canada.; Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, Montreal, QC, Canada.; Department of Medical Genetics, Research Institute, McGill University Health Centre, Montreal, QC, Canada.
McCluggage WG; Department of Pathology, Belfast Health and Social Care Trust, Royal Group of Hospitals Trust, Royal Group of Hospitals, Belfast, UK.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2016 Nov; Vol. 69 (5), pp. 727-738. Date of Electronic Publication: 2016 Jul 28.
Typ publikacji:
Journal Article
MeSH Terms:
Diagnosis, Differential*
Biomarkers, Tumor/*analysis
Carcinoma, Small Cell/*diagnosis
DNA Helicases/*biosynthesis
Neoplasms, Glandular and Epithelial/*diagnosis
Nuclear Proteins/*biosynthesis
Ovarian Neoplasms/*diagnosis
Transcription Factors/*biosynthesis
Carcinoma, Ovarian Epithelial ; DNA Helicases/analysis ; Female ; Humans ; Immunohistochemistry ; Nuclear Proteins/analysis ; Sensitivity and Specificity ; Tissue Array Analysis ; Transcription Factors/analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ovarian hilar proliferations resembling Sertoli cell tumours: microscopic neoplasms or non-neoplastic remnants?
Autorzy:
Taylor J; Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK.
Clarke BA; Department of Pathology and Laboratory Medicine, University Health Network, University of Toronto, Toronto, ON, Canada.
Hasan NU; Department of Pathology, St Helens and Knowsley Teaching Hospitals, Merseyside, UK.
Gasljevic G; Department of Pathology, Institute of Oncology, Ljubljana, Slovenia.
Cesari M; Department of Pathology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
McCluggage WG; Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2016 Mar; Vol. 68 (4), pp. 596-602. Date of Electronic Publication: 2015 Sep 04.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Ovarian Diseases/*pathology
Sertoli Cell Tumor/*pathology
Adult ; Diagnosis, Differential ; Female ; Humans ; Incidental Findings ; Middle Aged ; Ovarian Neoplasms/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet.
Autorzy:
He J; Department of Pathology and Laboratory Medicine, University of North Carolina, 111 Mason Farm Road, MBRB 2340B, Chapel Hill, NC, USA. .; General Hospital of Ningxia Medical University, Yinchuan, Ningxia, People's Republic of China. .
Quintana MT; Department of Surgery, University of North Carolina, Chapel Hill, NC, USA. .
Sullivan J; Department of Biology, University of North Carolina, Chapel Hill, NC, USA. .
L Parry T; McAllister Heart Institute, University of North Carolina, 111 Mason Farm Road, MBRB 2340B, Chapel Hill, NC, USA. .
J Grevengoed T; Department of Nutrition, University of North Carolina, Chapel Hill, NC, USA. .
Schisler JC; McAllister Heart Institute, University of North Carolina, 111 Mason Farm Road, MBRB 2340B, Chapel Hill, NC, USA. .; Department of Pharmacology, University of North Carolina, Chapel Hill, NC, USA. .
Hill JA; Department of Internal Medicine (Cardiology), University of Texas Southwestern Medical Center, Dallas, TX, USA. .
Yates CC; Department of Health Promotions and Development, School of Nursing, University of Pittsburgh, Pittsburgh, PA, USA. .
Mapanga RF; Cardio-Metabolic Research Group (CMRG), Department of Physiological Sciences, Stellenbosch University, Stellenbosch, 7600, South Africa. .
Essop MF; Cardio-Metabolic Research Group (CMRG), Department of Physiological Sciences, Stellenbosch University, Stellenbosch, 7600, South Africa. .
Stansfield WE; Department of Surgery, University of North Carolina, Chapel Hill, NC, USA. .
Bain JR; Sarah W. Stedman Nutrition and Metabolism Center, Duke Molecular Physiology Institute, Duke University Medical Center, Durham, NC, USA. .; Division of Endocrinology, Metabolism, and Nutrition, Department of Medicine, Duke University Medical Center, Durham, NC, USA. .
Newgard CB; Sarah W. Stedman Nutrition and Metabolism Center, Duke Molecular Physiology Institute, Duke University Medical Center, Durham, NC, USA. .; Division of Endocrinology, Metabolism, and Nutrition, Department of Medicine, Duke University Medical Center, Durham, NC, USA. .
Muehlbauer MJ; Sarah W. Stedman Nutrition and Metabolism Center, Duke Molecular Physiology Institute, Duke University Medical Center, Durham, NC, USA. .
Han Y; East Chapel Hill High School, Chapel Hill, NC, USA. .
Clarke BA; Novartis, Novartis Institutes for BioMedical Research, Inc., 400 Technology Square, Boston, MA, 601-4214, USA. brian.clarke@novartis.com.
Willis MS; Department of Pathology and Laboratory Medicine, University of North Carolina, 111 Mason Farm Road, MBRB 2340B, Chapel Hill, NC, USA. monte_.; McAllister Heart Institute, University of North Carolina, 111 Mason Farm Road, MBRB 2340B, Chapel Hill, NC, USA. monte_.
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2015 Aug 05; Vol. 14, pp. 97. Date of Electronic Publication: 2015 Aug 05.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Diet, High-Fat*
Weight Gain*
Cardiomyopathies/*prevention & control
Muscle Proteins/*metabolism
Myocardium/*enzymology
Obesity/*etiology
PPAR gamma/*metabolism
Animals ; Cardiomyopathies/enzymology ; Cardiomyopathies/etiology ; Cardiomyopathies/genetics ; Disease Models, Animal ; Female ; Gene Expression Regulation ; Genotype ; Insulin Resistance ; Male ; Mice, Knockout ; Muscle Proteins/deficiency ; Muscle Proteins/genetics ; Obesity/enzymology ; Obesity/genetics ; PPAR gamma/genetics ; Phenotype ; RNA, Messenger/metabolism ; Signal Transduction ; Time Factors ; Ubiquitination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Chromosomal instability as a prognostic marker in cervical cancer.
Autorzy:
How C; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. .
Bruce J; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. .
So J; Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. .; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada. .
Pintilie M; Division of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. .
Haibe-Kains B; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. .; Medical Biophysics Department, University of Toronto, Toronto, ON, Canada. .
Hui A; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. .
Clarke BA; Department of Pathology, University Health Network, Toronto, ON, Canada. blaise.clarke@uhn.on.ca.
Hedley DW; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. .; Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada. .
Hill RP; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. .
Milosevic M; Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. .; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada. .
Fyles A; Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. .; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada. .
Liu FF; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. .; Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. .; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2015 May 06; Vol. 15, pp. 361. Date of Electronic Publication: 2015 May 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Chromosomal Instability*
Biomarkers, Tumor/*genetics
Uterine Cervical Neoplasms/*genetics
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Middle Aged ; Prognosis ; Proportional Hazards Models ; Uterine Cervical Neoplasms/mortality ; Uterine Cervical Neoplasms/pathology ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Developing a prognostic micro-RNA signature for human cervical carcinoma.
Autorzy:
How C; Ontario Cancer Institute, University Health Network, Toronto, ON, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
Pintilie M; Division of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Bruce JP; Ontario Cancer Institute, University Health Network, Toronto, ON, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
Hui AB; Ontario Cancer Institute, University Health Network, Toronto, ON, Canada.
Clarke BA; Department of Pathology, University Health Network, Toronto, ON, Canada.
Wong P; Ontario Cancer Institute, University Health Network, Toronto, ON, Canada; Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
Yin S; Informatics & Biocomputing Platform, Ontario Institute for Cancer Research, Toronto, ON, Canada.
Yan R; Informatics & Biocomputing Platform, Ontario Institute for Cancer Research, Toronto, ON, Canada.
Waggott D; Informatics & Biocomputing Platform, Ontario Institute for Cancer Research, Toronto, ON, Canada.
Boutros PC; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada; Informatics & Biocomputing Platform, Ontario Institute for Cancer Research, Toronto, ON, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.
Fyles A; Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
Hedley DW; Ontario Cancer Institute, University Health Network, Toronto, ON, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada; Division of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Hill RP; Ontario Cancer Institute, University Health Network, Toronto, ON, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
Milosevic M; Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
Liu FF; Ontario Cancer Institute, University Health Network, Toronto, ON, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada; Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 Apr 16; Vol. 10 (4), pp. e0123946. Date of Electronic Publication: 2015 Apr 16 (Print Publication: 2015).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Expression Regulation, Neoplastic*
MicroRNAs/*genetics
Uterine Cervical Neoplasms/*genetics
Uterine Cervical Neoplasms/*mortality
Adult ; Aged ; Aged, 80 and over ; Disease-Free Survival ; Female ; Gene Expression Profiling/methods ; Humans ; Middle Aged ; Paraffin Embedding ; Prognosis ; Reproducibility of Results ; Uterine Cervical Neoplasms/pathology ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Microscopic extraovarian sex cord proliferations: an undescribed phenomenon.
Autorzy:
McCluggage WG; Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK.
Stewart CJ
Iacobelli J
Soma A
Cho KR
Heatley MK
Boyde A
Clarke BA
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2015 Mar; Vol. 66 (4), pp. 555-64. Date of Electronic Publication: 2014 Dec 22.
Typ publikacji:
Journal Article
MeSH Terms:
Cell Proliferation*
Fallopian Tube Neoplasms/*pathology
Granulosa Cell Tumor/*pathology
Ovarian Neoplasms/*pathology
Sex Cord-Gonadal Stromal Tumors/*pathology
Adult ; Female ; Humans ; Middle Aged ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study.
Autorzy:
Köbel M; Department of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, 1403 29 ST NW, Calgary, AB T2N 2T9, Canada.
Madore J; 1] Department of Pathology and Laboratory Medicine, University of British Columbia, BC Cancer Agency, 600 West 10th Avenue, Vancouver, BC V5E 4E6, Canada [2] Melanoma Institute Australia, University of Sydney, Royal Prince Alfred Hospital, Gloucester House-level 3, Missenden Road, Camperdown, NSW 2050, Australia.
Ramus SJ; Department of Preventive Medicine, Keck School of Medicine, USC/Norris Comprehensive Cancer Center, University of Southern California, Harlyne Norris Research Tower, 1450 Biggy Street, Office 2517G, Los Angeles, CA 90033, USA.
Clarke BA; Department of Laboratory Medicine and Pathobiology, Princess Margaret Cancer Centre, University of Toronto, 610 Univeristy Avenue, M-700, Toronto, ON M5T 2M9, Canada.
Pharoah PD; 1] Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 8RN, UK [2] Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 8RN, UK.
Deen S; Department of Histopathology, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK.
Bowtell DD; 1] Department of Cancer Genomics and Genetics, Peter MacCallum Cancer Centre, Locked Bag I, A'Beckett Street, East Melbourne, VIC 8006, Australia [2] Department of Biochemistry and Molecular Biology, University of Melbourne, 30 Flemington Road, Melbourne, VIC 3010, Australia [3] Sir Peter MacCallum Department of Oncology, University of Melbourne, 30 Flemington Road, Melbourne, VIC 3010, Australia.
Odunsi K; Department of Gynecological Oncology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
Menon U; Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, Maple House 1st Floor, 149 Tottenham Court Road, London W1T 7DN, UK.
Morrison C; Department of Pathology and Laboratory Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
Lele S; 1] Department of Gynecological Oncology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA [2] Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
Bshara W; Department of Pathology and Laboratory Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
Sucheston L; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
Beckmann MW; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Universitaetsstrasse 21-23, 91054 Erlangen, Germany.
Hein A; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Universitaetsstrasse 21-23, 91054 Erlangen, Germany.
Thiel FC; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Universitaetsstrasse 21-23, 91054 Erlangen, Germany.
Hartmann A; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Krankenhausstrasse 8-10, 91054 Erlangen, Germany.
Wachter DL; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Krankenhausstrasse 8-10, 91054 Erlangen, Germany.
Anglesio MS; Department of Pathology and Laboratory Medicine, University of British Columbia, BC Cancer Agency, 600 West 10th Avenue, Vancouver, BC V5E 4E6, Canada.
Høgdall E; 1] Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Strandboulevarden 49, DK-2100 Copenhagen, Ø, Denmark [2] Department of Pathology, Herlev Hospital, University of Copenhagen, Herlev Ringvej 75, DK-2370 Herlev, Denmark.
Jensen A; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Strandboulevarden 49, DK-2100 Copenhagen, Ø, Denmark.
Høgdall C; The Juliane Marie Center, Department of Obstetrics and Gynecology, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, DK-2100 Copenhagen, Ø, Denmark.
Kalli KR; Department of Medical Oncology, Mayo Clinic, 200 First Street SW, Charlton 6, Rochester, MN 55905, USA.
Fridley BL; Department of Biostatistics, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA.
Keeney GL; Department of Laboratory Medicine and Pathology, Division of Anatomic Pathology, Mayo Clinic, 200 First Street SW, Stabile 13, Rochester, MN 55905, USA.
Fogarty ZC; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, 200 First Street SW, Charlton 6, Rochester, MN 55905, USA.
Vierkant RA; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, 200 First Street SW, Charlton 6, Rochester, MN 55905, USA.
Liu S; Anatomic Pathology Research Laboratory, Calgary Laboratory Services, Foothills Medical Center, 1403 29 ST NW, Calgary, AB T2N 2T9, Canada.
Cho S; Department of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, 1403 29 ST NW, Calgary, AB T2N 2T9, Canada.
Nelson G; Department of Obstetrics and Gynecology, Division of Oncology, Tom Baker Cancer Centre, University of Calgary, Foothills Medical Center, 1403 29 ST NW, Calgary, AB T2N 2T9, Canada.
Ghatage P; Department of Obstetrics and Gynecology, Division of Oncology, Tom Baker Cancer Centre, University of Calgary, Foothills Medical Center, 1403 29 ST NW, Calgary, AB T2N 2T9, Canada.
Gentry-Maharaj A; Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, Maple House 1st Floor, 149 Tottenham Court Road, London W1T 7DN, UK.
Gayther SA; Department of Preventive Medicine, Keck School of Medicine, USC/Norris Comprehensive Cancer Center, University of Southern California, Harlyne Norris Research Tower, 1450 Biggy Street, Office 2517G, Los Angeles, CA 90033, USA.
Benjamin E; Department of Pathology, Cancer Institute, University College London, Maple House, 149 Tottenham Court Road, London WC1E 6JJ, UK.
Widschwendter M; Department of Women's Cancer, UCL EGA Institute for Women's Health, University College London, 74 Huntley Street, London WC1E 6AU, UK.
Intermaggio MP; Department of Preventive Medicine, Keck School of Medicine, USC/Norris Comprehensive Cancer Center, University of Southern California, Harlyne Norris Research Tower, 1450 Biggy Street, Office 2517G, Los Angeles, CA 90033, USA.
Rosen B; Department of Obstetrics and Gynecology, University of Toronto, Princess Margaret Cancer Centre, 610 University Avenue, M-700, Toronto, ON M5T 2M9, Canada.
Bernardini MQ; Department of Obstetrics and Gynecology, University of Toronto, Princess Margaret Cancer Centre, 610 University Avenue, M-700, Toronto, ON M5T 2M9, Canada.
Mackay H; Department of Medicine, Division of Medical Oncology, University of Toronto, Princess Margaret Hospital, 610 University Avenue, Toronto, ON M5G 2M9, Canada.
Oza A; Department of Obstetrics and Gynecology, University of Toronto, Princess Margaret Cancer Centre, 610 University Avenue, M-700, Toronto, ON M5T 2M9, Canada.
Shaw P; Department of Obstetrics and Gynecology, University of Toronto, Princess Margaret Cancer Centre, 610 University Avenue, M-700, Toronto, ON M5T 2M9, Canada.
Jimenez-Linan M; 1] Department of Pathology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK [2] National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK.
Driver KE; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 8RN, UK.
Alsop J; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 8RN, UK.
Mack M; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 8RN, UK.
Koziak JM; Department of Population Health Research, Alberta Health Services-Cancer Care, 2210 2nd Street SW, Calgary, AB, T2S 3C3, Canada.
Steed H; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Royal Alexandra Hospital, 10240 Kingsway Ave, Edmonton, AB T5H 3V9, Canada.
Ewanowich C; Department of Laboratory Medicine and Pathology, Royal Alexandra Hospital, 10240 Kingsway Ave, Edmonton, AB T5H 3V9, Canada.
DeFazio A; Department of Gynaecological Oncology and Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, NSW 2145, Australia.
Chenevix-Trench G; Genetics and Computational Biology Department, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, QLD,4006, Australia.
Fereday S; Department of Cancer Genomics and Genetics, Peter MacCallum Cancer Centre, Locked Bag I, A'Beckett Street, East Melbourne, VIC 8006, Australia.
Gao B; Department of Gynaecological Oncology and Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, NSW 2145, Australia.
Johnatty SE; Genetics and Computational Biology Department, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, QLD,4006, Australia.
George J; Department of Cancer Genomics and Genetics, Peter MacCallum Cancer Centre, Locked Bag I, A'Beckett Street, East Melbourne, VIC 8006, Australia.
Galletta L; Department of Cancer Genomics and Genetics, Peter MacCallum Cancer Centre, Locked Bag I, A'Beckett Street, East Melbourne, VIC 8006, Australia.
Goode EL; Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, 200 First Street SW Charlton 6, Rochester, MN 55905, USA.
Kjær SK; 1] Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Strandboulevarden 49, DK-2100 Copenhagen, Ø, Denmark [2] The Juliane Marie Center, Department of Obstetrics and Gynecology, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, DK-2100 Copenhagen, Ø, Denmark.
Huntsman DG; 1] Department of Pathology and Laboratory Medicine, University of British Columbia, BC Cancer Agency, 600 West 10th Avenue, Vancouver, BC V5E 4E6, Canada [2] Centre For Translational and Applied Genomics, British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, BC V5Z 4E6, Canada.
Fasching PA; 1] Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Universitaetsstrasse 21-23, 91054 Erlangen, Germany [2] Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Moysich KB; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
Brenton JD; 1] National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK [2] Department of Oncology, University of Cambridge, Hutchison/MRC Research Centre, Hills Road, Cambridge CB2 0XZ, UK [3] Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [4] Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK.
Kelemen LE; Department of Public Health Sciences, Medical University of South Carolina and Hollings Cancer Center, 135 Cannon Street, Charleston, SC 29425, USA.
Pokaż więcej
Corporate Authors:
AOCS Study Group
Źródło:
British journal of cancer [Br J Cancer] 2014 Dec 09; Vol. 111 (12), pp. 2297-307. Date of Electronic Publication: 2014 Oct 30.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Biomarkers, Tumor/*biosynthesis
Folate Receptor 1/*biosynthesis
Neoplasms, Glandular and Epithelial/*metabolism
Ovarian Neoplasms/*metabolism
Carcinoma, Ovarian Epithelial ; Disease-Free Survival ; Female ; Humans ; Immunohistochemistry ; Middle Aged ; Survival Analysis ; Tissue Array Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 32

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies